Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug;16(8):431.
doi: 10.1007/s11926-014-0431-x.

Vaccinations for rheumatoid arthritis

Lisa M Perry  1 , Kevin L Winthrop, Jeffrey R Curtis
Affiliations
Review

Vaccinations for rheumatoid arthritis

Lisa M Perry et al. Curr Rheumatol Rep. 2014 Aug.

Abstract

Patients with rheumatoid arthritis (RA) suffer an increased burden of infectious disease-related morbidity and mortality and have twice the risk of acquiring a severe infection compared to the general population. This increased risk is not only a result of the autoimmune disease but is also attributed to the immunosuppressive therapies that are commonly used in this patient population. Given the increase in infection-related risks in RA, there is great interest in mitigating such risk. A number of vaccines are available to the rheumatologist, with a handful that are of importance for RA patients in the United States. The goal of this paper is to highlight the most recent literature on the key vaccines and the specific considerations for the rheumatologist and their RA patients, with a particular focus on influenza, pneumococcal, and herpes zoster vaccines. It is important for rheumatologist to understand and be aware of which vaccines are live and what potential contraindications exist for giving vaccines to RA patients.

PubMed Disclaimer

References

    1. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis and rheumatism. 1994 Apr;37(4):481–94. PubMed PMID: 8147925. - PubMed
    1. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE. Predictors of infection in rheumatoid arthritis. Arthritis and rheumatism. 2002 Sep;46(9):2294–300. PubMed PMID: 12355476. - PubMed
    1. Gluck T, Muller-Ladner U. Vaccination in patients with chronic rheumatic or autoimmune diseases. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2008 May 1;46(9):1459–65. PubMed PMID: 18419456. - PubMed
    1. Grijalva CG, Chen L, Delzell E, Baddley JW, Beukelman T, Winthrop KL, et al. Initiation of tumor necrosis factor-alpha antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA : the journal of the American Medical Association. 2011 Dec 7;306(21):2331–9. PubMed PMID: 22056398. Pubmed Central PMCID: 3428224. - PMC - PubMed
    1. Crowson CS, Hoganson DD, Fitz-Gibbon PD, Matteson EL. Development and validation of a risk score for serious infection in patients with rheumatoid arthritis. Arthritis and rheumatism. 2012 Sep;64(9):2847–55. PubMed PMID: 22576809. Pubmed Central PMCID: 3424339. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources